The developed sustained release tablets have acceptable
FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF VILDAGLIPTIN
7
FORMULATION AND EVALUATION OF MIGLITOL SUSTAINED RELEASE TABLETS
5
Formulation and Evaluation of Nicardipine Sustained Release Tablets
5
Formulation and evaluation of magnesium sustained release tablets
6
Effect of different polymers on release of the sustained release tablets of the glipizide
8
Sustained release aceclofenac matrix tablets constituting Kollidon sustained release (KSR) (polyvinyl acetate and
8
Formulation Development and Evaluation of Sustained Release Tablets of Aceclofenac
128
Formulation and Evaluation of Ondansetron Hydrochloride Sustained Release Tablets
113
Formulation and Evaluation of Tamsulosin Hydrochloride Sustained Release Tablets.
103
Development and Evaluation of Sustained Release Bilayer Tablets of Carvedilol.
113
Formulation Development of Metformin Hydrochloride Sustained Release Tablets
137
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF PIOGLITAZONE
22
FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF VALSARTAN
15
FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE TABLETS OF LORNOXICAM
8
FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF MEFORMIN HYDROCHLORIDE
17
FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF LORATADINE
11
DESIGN AND EVALUATION OF LAMOTRIGINE ORAL SUSTAINED RELEASE TABLETS
6
DESIGN AND IN VITRO EVALUATION OF SUSTAINED RELEASE TABLETS OF RANOLAZINE
7
Formulation and Evaluation of Nitazoxanide Sustained-Release Matrix Tablets
9
FORMULATION AND IN VITRO CHARACTERIZATION OF SUSTAINED RELEASE TABLETS OF PRIMIDONE
10